• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Eosinophil-associated intestinal immune responses following SARS-CoV-2 infection in K18-hACE2 mice

tetano

Editor, Senior Moderator
PLoS One


. 2026 Aug 12;21(8):e0355607.
doi: 10.1371/journal.pone.0355607. eCollection 2026.
Eosinophil-associated intestinal immune responses following SARS-CoV-2 infection in K18-hACE2 mice

Shun Tamaki[SUP] 1 2 3 [/SUP], Rei Kawashima[SUP] 1 2 3 [/SUP], Takayuki Uematsu[SUP] 4 5 [/SUP], Fumitaka Kawakami[SUP] 2 3 6 [/SUP], Motoki Imai[SUP] 3 7 8 [/SUP], Yoshifumi Kurosaki[SUP] 2 3 9 [/SUP], Toshihide Matsumoto[SUP] 3 10 [/SUP], Shotaro Maehana[SUP] 3 11 12 [/SUP], Yusuke Hara[SUP] 1 13 14 [/SUP], Setsuko Sugawara[SUP] 1 2 3 [/SUP], Hiroki Izawa[SUP] 3 11 12 [/SUP], Takafumi Ichikawa[SUP] 1 2 3 [/SUP], Hidero Kitasato[SUP] 3 11 12 [/SUP], Hideaki Hanaki[SUP] 15 [/SUP], Makoto Kubo[SUP] 3 11 12 [/SUP]


Affiliations
Abstract

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is frequently associated with gastrointestinal manifestations; however, intestinal immune responses following SARS-CoV-2 infection remain incompletely understood. This study aimed to characterize eosinophil-associated intestinal immune responses in SARS-CoV-2-infected K18-hACE2 transgenic mice.
Methods: Small intestinal tissues from infected mice were analyzed using cytokine and chemokine PCR arrays, qRT-PCR, immunohistochemistry, and histological analyses.
Results: SARS-CoV-2 infection was associated with marked upregulation of Il5 mRNA in small intestinal tissues, along with increased expression of eosinophil-related cytokines and chemokines, including Ccl24 and Ccl11. Immunohistochemical analyses showed eosinophil accumulation in the lamina propria, accompanied by increased signals for eosinophil-associated granule proteins, including major basic protein and eosinophil peroxidase. Additional qRT-PCR analyses showed increased expression of Prg2 and Epx, further supporting eosinophil granule protein-associated responses. Charcot-Leyden crystals and increased Galectin-10 expression were also observed. Temporal analyses showed an acute Il5/Ccl24-related response followed by delayed Ccl11 upregulation during later stages.
Conclusions: These findings indicate that SARS-CoV-2 infection is associated with eosinophil-associated intestinal immune responses in K18-hACE2 mice. Although eosinophil activation or intestinal allergy was not directly demonstrated, this study supports virus-associated eosinophil-related intestinal responses as a possible framework for understanding allergy-like intestinal immune alterations during SARS-CoV-2 infection.


 
Back
Top